Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06282575
Title Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Jazz Pharmaceuticals
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.